Advertisement
News
Subscribe to Pharmaceutical Processing News

The Lead

AbbVie completes acquisition of Pharmacyclics

May 26, 2015 | by PRNewswire | Comments

"The companies' shared expertise, combined with AbbVie's broad late-stage oncology pipeline, has the potential to transform the cancer treatment landscape for hematological malignancies and improve patient outcomes and quality of life," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. 

TOPICS:

Actavis confirms court ruling related to NAMENDA

May 26, 2015 11:17 am | by PRNewswire | Comments

"While we are disappointed by the Court's decision to uphold this ruling, we intend to continue our strong efforts to convey the significant benefits of NAMENDA XR@ to physicians, patients and caregivers," said Brent Saunders, CEO and President of Actavis.

TOPICS:

Implantable drug delivery systems continue growth trend

May 26, 2015 11:10 am | by Business Wire | Comments

The expected growth of the market can be attributed to several factors.

TOPICS:

Rhodes Pharmaceuticals' announces launch of daily treatment for ADHD

May 22, 2015 9:59 am | by PRNewswire | Comments

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.

TOPICS:
Advertisement

Chinese consortium to jointly acquire U.S. biotechnology company Ambrx

May 22, 2015 9:42 am | by PRNewswire | Comments

A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund ("CEL Healthcare Fund"), and WuXi PharmaTech announced today that the Consortium ...

TOPICS:

EMA recommends suspending medicines over flawed studies

May 22, 2015 9:31 am | Comments

The European Medicines Agency (EMA) has confirmed its recommendation to suspend a number of medicines for which authorisation in the European Union (EU) was primarily based on clinical studies conducted at GVK Biosciences in Hyderabad, India.

TOPICS:

Tribute Pharmaceuticals announces expansion into U.S. market

May 21, 2015 4:21 pm | by Associated Press | Comments

Tribute Pharmaceuticals Canada Inc., a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., is pleased to announce that its wholly owned subsidiary ...

TOPICS:

Achillion shares sink after partnering with Johnson & Johnson

May 21, 2015 11:56 am | by TOM MURPHY, AP Business Writer | Comments

Investors started shedding Achillion shares early Wednesday, less than a day after the drugmaker announced a partnership with pharmaceutical giant Johnson & Johnson that snuffed out the prospect of a near-term acquisition. Achillion and Johnson & Johnson's Janssen Pharmaceutical Companies ...

TOPICS:

DEA raids clinics, pharmacies in 'pill mill' crackdown

May 21, 2015 11:46 am | by CLAUDIA LAUER & ALICIA A. CALDWELL, Associated Press | Comments

Authorities raided medical clinics, pharmacies and other locations across the South on Wednesday as part of a Drug Enforcement Administration attempt to thwart illegal prescription drug sales. The raids in Arkansas, Alabama, Louisiana and Mississippi were the latest ...

TOPICS:
Advertisement

4 shops sold marijuana to minors in sting operations

May 21, 2015 11:43 am | by GENE JOHNSON, Associated Press | Comments

Four of the 22 legal pot shops tested in an initial round of sting operations this month failed by selling to minors — even though the shops were warned about the operations days ahead of time, Washington regulators said Wednesday. Two shops in Tacoma and two in Everett ...

CVS to Acquire Drug Distributor Omnicare for $10.4 B

May 21, 2015 11:34 am | by TOM MURPHY, AP Business Writer | Comments

CVS Health will spend more than $10 billion to buy pharmacy services provider Omnicare and tap a growing target for prescription drug distribution: care for the elderly. The deal announced Thursday will give one of the nation's biggest pharmacy benefits ...

TOPICS:

Endo’s Purchase of Par Pharma Shakes up the Industry

May 21, 2015 11:03 am | Comments

US Pharma M&A activity has yet to show any signs of a slowdown after the $8.1bn exit of Par Pharma by TPG to Endo was announced on Monday. The US Pharma industry has seen 39 deals valued at US$ 77.3bn to-date, three more deals announced ...

TOPICS:

Domino Printing Shows Off New Fiber Laser at INTERPHEX

May 21, 2015 10:56 am | Comments

Domino Printing provided live demonstrations of their latest laser technology innovations, plus their partnerships with Omega Design and 3C! Packaging to help healthcare companies address strict packaging requirements at the International Pharmaceutical Expo (INTERPHEX)....

TOPICS:

FDA Cautions About Dose Confusion and Medication Errors

May 21, 2015 10:23 am | Comments

The U.S. Food and Drug Administration (FDA) is warning health care professionals about the risk for dosing errors with the antibacterial drug Zerbaxa (ceftolozane and tazobactam) due to confusion about the drug strength displayed on the vial and carton labeling.

TOPICS:

USP demands public standards for dietary supplements

May 21, 2015 10:06 am | by United States Pharmacopeial Convention | Comments

In recent weeks, the case of supplements containing an amphetamine-like substance called BMPEA has prompted FDA recalls; industry trade group condemnation; appeals from Congress for increased enforcement, consumer education campaigns and greater participation by ...

TOPICS:

Report: Mesothelioma Drug Could Extend Patients’ Lives

May 20, 2015 12:06 pm | by Associated Press | Comments

Results of a clinical trial conducted by a team of Italian researchers showed a new drug could extend the lives of patients suffering from malignant mesothelioma, the mesothelioma law firm of Baron & Budd reports. The results were published in the April issue of the medical journal The Lancet.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading